Pulse Biosciences Inc EV/EBIT
Was ist das EV/EBIT von Pulse Biosciences Inc?
EV/EBIT von Pulse Biosciences Inc ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Pulse Biosciences Inc
Was macht Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Unternehmen mit ev/ebit ähnlich Pulse Biosciences Inc
- Avacta Plc hat EV/EBIT von N/A
- Circassia Pharmaceuticals Plc hat EV/EBIT von N/A
- Sparta Capital hat EV/EBIT von N/A
- Anterix hat EV/EBIT von N/A
- Bajaj Hindusthan Sugar hat EV/EBIT von N/A
- Reliance Naval and Engineering hat EV/EBIT von N/A
- Pulse Biosciences Inc hat EV/EBIT von N/A
- Pluralsight Inc hat EV/EBIT von N/A
- Scor Se hat EV/EBIT von N/A
- Prairie Mining hat EV/EBIT von N/A
- Desert Mountain hat EV/EBIT von N/A
- Acreage hat EV/EBIT von N/A
- F45 Training hat EV/EBIT von N/A